semaglutide side effects kidney does cause problems Cardio-kidney-metabolic protective of across the spectrum of chronic disease effect of semaglutide on chronic – Ozempic and GLP-1 Drugs: Risk

The new research published in April 2026 showed improved blood pressure and cholesterol markers in participants, but a dedicated cardiovascular outcomes trial with hard endpoints is still in progress

So for GLP-1s, we know that there is a lot of benefit in terms of reduced events and deaths for people who have heart diseasetheir risk of heart attack and stroke is decreased

The medication that works for someone else might not work for you

According to available data in non-surgical patients, early treatment response (13 months) to the weight loss drug seems to be a good predictor of long-term weight maintenance [31,32,33,34]

metoprolol), and medicines used for treating Parkinson's disease (e.g